2025-524852-74-00CompletedPhase 1
A clinical trial of MK-3214 taken with different liquids in healthy participants (MK-3214-002)
Source: EU CTIS (euclinicaltrials.eu) · Last updated 6 Mar 2026
- Status (registry)
- Completed
- Phase (registry)
- Phase 1
- Study type
- Interventional
- Enrollment
- 32 (actual)
- First submitted
- 26 Jan 2026
- Start date
- Mar 2026
- Lead sponsor
- Merck Sharp & Dohme LLC
- EU CT number
- 2025-524852-74-00
What you commit to
- Study type: Interventional · Phase 1
- Participants enrolled: 32
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Universitair Ziekenhuis Gent | Gent | Belgium | Completed |
This page is information, not medical advice. Discuss any trial with your doctor.